Web.com Announces Agreement to Acquire Donweb.com
Dec 12, 2016 21:05 pm UTC| Business
Important driver of Web.com's international growth strategyPlatform for Latin American market JACKSONVILLE, Fla., Dec. 12, 2016 -- Web.com Group, Inc. (Web.com) (NASDAQ:WEB), a leading provider of Internet services...
II-VI Marlow Announces Distribution Partnership with Digi-Key Electronics
Dec 12, 2016 21:05 pm UTC| Business
PITTSBURGH, Dec. 12, 2016 -- The II-VI Marlow Division of II‐VI Incorporated (NASDAQ:IIVI), a leading provider of high quality, high performance thermoelectric solutions, today announced an exclusive, global agreement...
Dec 12, 2016 21:01 pm UTC| Business
Focus on oral formulationPhase II complete THE WOODLANDS, Texas, Dec. 12, 2016 -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced it has requested a meeting to discuss Phase 3 requirements for the development...
Dec 12, 2016 21:01 pm UTC| Business
MARYSVILLE, Ohio, Dec. 12, 2016 -- The Scotts Miracle-Gro Company (NYSE:SMG) announced today the pricing of its offering of $250 million aggregate principal amount of 5.250% senior notes due 2026 (the “Senior Notes”)....
Achaogen Announces Proposed Public Offering of Common Stock
Dec 12, 2016 21:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 12, 2016 -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...
Aspen Group Reports 81% Revenue Growth and Positive Net Income in the Fiscal 2017 Second Quarter
Dec 12, 2016 21:01 pm UTC| Business
NEW YORK, Dec. 12, 2016 -- Aspen Group, Inc. (OTCQB:ASPU) (“Aspen”), a nationally accredited online post-secondary education company (Aspen University), today announced financial results for its 2017 fiscal second...
Arbutus Provides Additional Data from the ARB-1467 Phase II Clinical Trial in HBV Patients
Dec 12, 2016 21:00 pm UTC| Business
Complete Cohort 1 and 2 ARB-1467 Multi-Dose Data Demonstrate Dose-Responsive HBsAg ReductionsGreater Than 1.0 log10 Reduction in Serum HBsAg Observed in 3/5 Patients After Receiving Three Monthly Doses of ARB-1467 at 0.4...